Business Context and Reporting Period
The filing is Healthcare Trust, Inc.’s Form 10-K for the fiscal year ended December 31, 2018. The request metadata identifies National Healthcare Properties, Inc.; the provided filing text identifies the registrant as Healthcare Trust, Inc. The company is an externally managed healthcare REIT focused on medical office buildings, seniors housing and other healthcare facilities in the United States.
- Portfolio at year-end: 191 properties in 31 states and 9.1 million rentable square feet.
- Gross asset value: $2.6 billion; annualized straight-line rental income: $348.6 million.
- Segments: medical office buildings, triple-net leased healthcare facilities and seniors housing operating properties under a RIDEA structure.
- Shares outstanding at December 31, 2018: 91.96 million; no established public trading market existed.
Financial Performance and Key Metrics
| Metric | 2018 | 2017 | Change |
|---|---|---|---|
| Total revenues | $362.4 million | $311.2 million | Up 16.5% |
| Operating loss | $3.2 million | $12.2 million | Improved $9.0 million |
| Net loss attributable to stockholders | $52.8 million | $42.5 million | Loss increased $10.2 million |
| Net loss per share | $0.58 | $0.47 | Loss increased |
| Cash flow from operations | $54.2 million | $64.0 million | Down 15.3% |
| FFO attributable to stockholders | $49.7 million | $51.8 million | Down 4.1% |
| MFFO attributable to stockholders | $45.1 million | $48.4 million | Down 6.8% |
| NOI | $141.4 million | $124.9 million | Up 13.2% |
Revenue growth was driven primarily by a $39.4 million increase in seniors housing resident services and fee income and a $7.6 million increase in rental income. Property operating expenses increased 18.6% to $221.0 million, while depreciation and amortization increased to $83.2 million. Interest expense increased 63.5% to $49.5 million, reflecting higher debt balances and interest rates.
- Cash and cash equivalents: $77.3 million; restricted cash: $14.1 million.
- Total assets: $2.38 billion; total equity: $1.24 billion.
- Mortgage notes payable, net: $462.8 million; credit facilities: $602.6 million.
- Total debt leverage ratio: approximately 45.2%; total borrowings: approximately $1.1 billion at a weighted-average interest rate of 4.6%.
- 2018 capital expenditures: $12.9 million; real estate investment and development funding: $128.1 million.
Material Changes Versus the Prior Comparable Period
- The company acquired 14 properties in 2018, including 12 medical office buildings and two triple-net leased properties, for approximately $128.1 million of real estate investment.
- Eight Missouri skilled nursing facilities were sold for $27.5 million, generating an impairment charge and a $0.1 million loss on sale.
- The company recognized $20.7 million of impairment charges, compared with $19.0 million in 2017. The charges included approximately $11.9 million on the Missouri properties and $6.4 million on six New York medical office buildings classified as held for sale.
- Six properties were transitioned from the triple-net leased segment to the SHOP segment. Transition properties contributed $5.2 million of 2018 NOI versus $0.8 million in 2017, but the transition increased operating exposure and regulatory complexity.
- Bad debt expense was $13.4 million, primarily related to defaulting NuVista and LaSalle tenants. The company fully reserved $9.4 million owed by the NuVista tenants and $4.2 million owed by the LaSalle tenant.
- The board reduced the annualized distribution rate from $1.45 per share to $0.85 per share effective March 1, 2018. Distributions declared for 2018 were $0.95 per share and were classified entirely as return of capital for tax purposes.
- Distributions totaled $91.5 million, while operating cash flow was $54.2 million. Approximately 59.2% of distributions was funded from operating cash flow, 35.2% from DRIP proceeds and the remainder from cash on hand and other sources.
Guidance, Outlook, Risks and Unusual Items
Management expects to fund near-term liquidity needs through cash on hand, operating cash flow, DRIP proceeds, property dispositions and secured financing. The filing does not provide quantitative earnings or distribution guidance. Management states that distributions may be reduced or suspended and are not assured.
- New credit facility: On March 13, 2019, after year-end, the company replaced its Prior Credit Facility with a new facility having $630.0 million of total commitments and an accordion feature of up to $370.0 million. At closing, borrowing capacity based on the borrowing base was $263.1 million, of which $233.6 million was outstanding and $29.5 million was available.
- Liquidity and maturities: The company had $38.3 million of scheduled mortgage principal payments due in 2019. The Prior Credit Facility had $243.3 million outstanding at December 31, 2018 and was scheduled to mature in March 2019; it was subsequently amended and restated.
- Jupiter development: The company had funded $90.6 million for the Jupiter, Florida development, including $80.6 million of construction in progress, and had funded $8.6 million above its $72.0 million construction commitment. The developer was in default, the certificate of occupancy had not been obtained, and the property had generated no rental income.
- Tenant defaults: Collection problems involving NuVista and LaSalle tenants adversely affected earnings and cash flow. A court judgment of $8.8 million was entered against a NuVista tenant in February 2019, but recovery was uncertain and fully reserved.
- New York dispositions: Five of the six New York MOBs were sold on February 6, 2019 for $45.0 million, with net proceeds of $26.6 million after closing costs and debt repayment. The remaining property remained held for sale.
- Interest-rate risk: A 100-basis-point increase in variable rates was estimated to increase annual interest expense by approximately $1.6 million. The company also faced LIBOR transition risk.
- Industry and regulatory risks: Tenant performance depends on healthcare reimbursement, licensure, Medicare and Medicaid policy, fraud-and-abuse enforcement, healthcare regulation, occupancy, labor costs and private-pay resident demand.
- Governance and liquidity risks: The company has no employees, relies on its Advisor and Property Manager, pays substantial related-party fees and has conflicts-of-interest exposure. Its shares remained illiquid and the share repurchase program was limited and subject to board discretion.
Most Important Facts for Investors to Verify
- Confirm the registrant’s identity because the supplied metadata names National Healthcare Properties, Inc., while the filing names Healthcare Trust, Inc.
- Reconcile the sustainability of the $0.85-per-share annualized distribution against $54.2 million of operating cash flow and $91.5 million of total distributions.
- Review debt maturities, covenant compliance, borrowing-base availability and the terms of the March 2019 New Credit Facility.
- Assess recoverability of the Jupiter development investment, the certificate-of-occupancy status and the likelihood of obtaining a replacement tenant.
- Monitor collections, legal proceedings and operator transitions involving the NuVista and LaSalle tenants.
- Evaluate the effect of the 45.2% leverage ratio, variable-rate debt, refinancing requirements and LIBOR replacement on future interest expense.
- Review impairment assumptions and the carrying values of held-for-sale and underperforming properties.
- Distinguish GAAP net loss from FFO, MFFO and NOI, which are non-GAAP measures and are not substitutes for operating cash flow or liquidity.